KraneShares MSCI All China Health Care Index ETF (KURE) |
| 17.62 -0.18 (-1.01%) 10-30 16:00 |
| Open: | 17.62 |
| High: | 17.6899 |
| Low: | 17.5001 |
| Volume: | 21,417 |
| Market Cap: | 108(M) |
| PE Ratio: | 26.46 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 19.63 |
| Resistance 1: | 18.74 |
| Pivot price: | 17.86 |
| Support 1: | 17.30 |
| Support 2: | 14.39 |
| 52w High: | 19.93 |
| 52w Low: | 14.38 |
This exchange-traded fund will allocate at least 80% of its net assets, including any capital acquired through borrowing for investment purposes, to financial instruments that are components of its underlying index or exhibit similar economic characteristics. The reference index is a market capitalization-weighted measure, adjusted for free float, and applies a 10/40 Constraint. Its objective is to gauge the equity market performance of Chinese enterprises within the healthcare sector. This fund does not maintain a diversified portfolio.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 22 Oct 2026
Healthcare ETF: China May Control A Key Bottleneck In AI Drug Discovery - Seeking Alpha
Wed, 21 Oct 2026
Healthcare ETF: China May Control a Key Bottleneck in AI Drug Discovery - KraneShares
Mon, 28 Sep 2026
MRNA Stock Eyes Best Year Ever: Analyst Calls China’s AI Drug Lead ‘Baseless’ As Moderna Awaits Cancer Data - TradingView
Fri, 18 Sep 2026
Healthcare ETF: Treatment Breakthroughs Make China A Medical Destination - KraneShares
Mon, 15 Jun 2026
Healthcare ETF: Outbound Biotech Licensing As Potential New Growth Driver In China - KraneShares
Mon, 11 May 2026
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |